PMID: 9434928Jan 22, 1998Paper

Organization of intensive care units in Europe: lessons from the EPIC study

Intensive Care Medicine
J L VincentH Bruining

Abstract

To study differences related to intensive care unit (ICU) structure and patient demography between the various countries of Western Europe. Application of data collected by the European Prevalence of Infection in Intensive Care (EPIC) study, a one-day prevalence study. Voluntary participation of all Western European ICUs. A total of 1417 ICUs responded. All patients, older than 10 years of age, occupying a bed in the participating ICUs over a 24-h period. 10,038 patient case reports were submitted. The study revealed important differences. In particular, there seems to be a north/south divide with fewer ICU beds and more severely ill patients in the south. The United Kingdom seemed more similar to southern European countries than to the north. While there are similarities between European countries, large differences still remain and are important to identify to enable us to work together to create a more uniform system of intensive care, which will in turn give more effective and efficient patient care.

Citations

Aug 21, 2008·Intensive Care Medicine·Evangelos PapadomichelakisHelen Giamarellou
Nov 21, 2000·Lancet·J L Vincent
Jun 20, 2003·Lancet·Jean-Louis Vincent
May 23, 2012·The New England Journal of Medicine·Victoria Campbell
May 22, 2013·The New England Journal of Medicine·Meeta Prasad KerlinScott D Halpern
Feb 9, 2005·Critical Care Medicine·Arzu TopeliMartin J Tobin
Jan 6, 2009·Critical Care Medicine·Jean-Louis Vincent
Aug 3, 2010·American Journal of Respiratory and Critical Care Medicine·Elie AzoulayLaurent Brochard
Aug 3, 2010·American Journal of Respiratory and Critical Care Medicine·Timothy W Evans
Apr 3, 2012·American Journal of Respiratory and Critical Care Medicine·Jordi Mancebo, Jesse Hall
Jan 13, 2006·BMC Health Services Research·Pengyu CaoKouhei Akazawa
Dec 21, 2013·Cell and Tissue Banking·P Edwin Vorstius KruijffRob Slappendel
Aug 27, 2014·Journal of the American College of Surgeons·Spyridon FortisGreg Beilman
Nov 6, 1998·Intensive Care Medicine·B DepasseJ L Vincent
Jan 22, 1998·Intensive Care Medicine·W J SibbaldC M Martin
Sep 25, 2010·Wiener klinische Wochenschrift·Jürgen GrafUNKNOWN German Competence Network Sepsis (SepNet)
Aug 6, 2002·Scandinavian Journal of Infectious Diseases·Anna FarraUNKNOWN Swebact Study Group
Apr 8, 2009·Chest·Ognjen Gajic, Bekele Afessa
Feb 13, 2013·Medicina intensiva·L BlanchJ Mancebo
Dec 8, 2004·Critical Care Clinics·Steven Y ChangJesse B Hall
May 20, 2015·Anaesthesia Critical Care & Pain Medicine·Jean-Yves LefrantUNKNOWN AzuRea Group
Nov 22, 2002·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·D K BeattieA H Davies
Sep 12, 2000·The Journal of Hospital Infection·N H O'Connell, H Humphreys
Jun 29, 2016·Intensive Care Medicine·Bertrand GuidetKathryn Rowan
Sep 3, 2016·Intensive Care Medicine·Gary E Weissman, Scott D Halpern
Jun 28, 2016·Critical Care Medicine·Yaseen M ArabiUNKNOWN Asian Critical Care Clinical Trials Group
Nov 15, 2017·Critical Care Medicine·Megan GallowayDavid Harrison
Jul 10, 2018·Critical Care Medicine·Lotte KokDieuwke S Veldhuijzen
Sep 27, 2012·Sociology of Health & Illness·Simon Carmel
Mar 29, 2014·Current Opinion in Otolaryngology & Head and Neck Surgery·Brendan A McGrath, Sarah Wallace
Mar 3, 2010·American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses·Mariusz WysokinskiWieslaw Fidecki
Dec 16, 2003·Intensive Care Medicine·Benoit MissetJean Carlet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.